Please use this identifier to cite or link to this item: https://ahro.austin.org.au/austinjspui/handle/1/19323
Title: Hereditary leiomyomatosis and renal cell cancer syndrome: a family affair.
Austin Authors: Teh, Jiasian ;Kinnear, Ned J;Douglass-Molloy, Hannah;Hennessey, Derek Barry
Affiliation: Austin Health, Heidelberg, Victoria, Australia
Royal Adelaide Hospital, Adelaide, South Australia, Australia
Issue Date: 25-Jan-2017
metadata.dc.date: 2017
Publication information: BMJ Case Reports 2017; 2017: bcr-2016-218270
Abstract: A 49-year-old woman with cutaneous and uterine leiomyomas, flank pain and a family history of hereditary leiomyomatosis and renal cell cancer (HLRCC) syndrome sought genetic testing. She was found to harbour a fumarate hydratase (FH) genetic mutation and a previously undetected renal tumour. The patient underwent radical nephrectomy, and remains well at follow-up. HLRCC syndrome is a rare autosomal dominant disease, with patients at increased risk for cutaneous leiomyomas, early-onset uterine leiomyomas and aggressive renal carcinoma. Although the syndrome may manifest life-threatening complications, outcomes may be improved by preventative family screening and surveillance, compelling early diagnosis.
URI: http://ahro.austin.org.au/austinjspui/handle/1/19323
DOI: 10.1136/bcr-2016-218270
ORCID: 0000-0002-7833-2537
0000-0002-7372-0100
PubMed URL: 28122802
Type: Journal Article
Appears in Collections:Journal articles

Show full item record

Page view(s)

8
checked on Dec 9, 2022

Google ScholarTM

Check


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.